429 related articles for article (PubMed ID: 8163691)
1. Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
Leiper K; Croll A; Booth NA; Moore NR; Sinclair T; Bennett B
J Clin Pathol; 1994 Mar; 47(3):214-7. PubMed ID: 8163691
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis.
Tran-Thang C; Fasel-Felley J; Pralong G; Hofstetter JR; Bachmann F; Kruithof EK
Thromb Haemost; 1989 Sep; 62(2):651-3. PubMed ID: 2510345
[TBL] [Abstract][Full Text] [Related]
3. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
4. Distribution of plasminogen activator inhibitor in normal liver, cirrhotic liver, and liver with metastases.
Fitch P; Bennett B; Booth NA; Croll A; Ewen SW
J Clin Pathol; 1994 Mar; 47(3):218-21. PubMed ID: 8163692
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of tissue plasminogen activator (t-PA) levels in patients with liver diseases.
Okabe K; Kato I; Sato S; Kashiwabara T; Furuta S; Sato H; Tanikawa K; Kumashiro R; Kanayama M
Gastroenterol Jpn; 1992 Feb; 27(1):61-8. PubMed ID: 1313384
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
7. Profound imbalance of pro-fibrinolytic and anti-fibrinolytic factors (tissue plasminogen activator and plasminogen activator inhibitor type 1) and severe bleeding diathesis in a patient with cirrhosis: correction by liver transplantation.
Kahl BS; Schwartz BS; Mosher DF
Blood Coagul Fibrinolysis; 2003 Dec; 14(8):741-4. PubMed ID: 14614353
[TBL] [Abstract][Full Text] [Related]
8. Induction of hepatic tissue-type plasminogen activator and type 1 plasminogen activator-inhibitor gene expressions and appearance of their translation products in the bile following acute liver injury in rats.
Noguchi T; Matsuyama S; Akao M; Hagiwara H; Uno S; Seki T; Ariga T
Thromb Res; 2001 Nov; 104(4):283-91. PubMed ID: 11728530
[TBL] [Abstract][Full Text] [Related]
9. Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (t-PA) and t-PA/PAI-1 complex in plasma.
Chandler WL; Trimble SL; Loo SC; Mornin D
Blood; 1990 Sep; 76(5):930-7. PubMed ID: 2118399
[TBL] [Abstract][Full Text] [Related]
10. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis.
Huber K; Kirchheimer JC; Korninger C; Binder BR
Thromb Res; 1991 Jun; 62(5):491-500. PubMed ID: 1910213
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activators and their inhibitors in leukemic cell homogenates.
Wada H; Kumeda Y; Ogasawara Z; Ohiwa M; Kaneko T; Tamaki S; Ohno T; Kageyama S; Kobayashi T; Deguchi K
Am J Hematol; 1993 Feb; 42(2):166-70. PubMed ID: 8438877
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the mechanism of hyperfibrinolysis in liver cirrhosis--changes of plasma t-PA, PAI-1 and active PAI-1 levels in liver cirrhosis].
Matsuura R; Soma M; Maeda Y; Kasakura S
Rinsho Byori; 1995 Dec; 43(12):1256-60. PubMed ID: 8569037
[TBL] [Abstract][Full Text] [Related]
13. Measurements of the concentration of free plasminogen activator inhibitor (PAI-1) and its complex with tissue plasminogen activator in human plasma.
Takada Y; Takada A
Thromb Res Suppl; 1988; 8():15-22. PubMed ID: 3144765
[TBL] [Abstract][Full Text] [Related]
14. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.
Rydzewski A; Sakata K; Kobayashi A; Yamazaki N; Urano T; Takada Y; Takada A
Haemostasis; 1990; 20(5):305-12. PubMed ID: 2127039
[TBL] [Abstract][Full Text] [Related]
15. Molecular forms of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in human plasma.
Alessi MC; Juhan-Vague I; Declerck PJ; Collen D
Thromb Res; 1991 May; 62(4):275-85. PubMed ID: 1907771
[TBL] [Abstract][Full Text] [Related]
16. Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.
Lucore CL; Fujii S; Sobel BE
Circulation; 1989 Jun; 79(6):1204-13. PubMed ID: 2498004
[TBL] [Abstract][Full Text] [Related]
17. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tissue plasminogen activator activity by aspirin in vivo and its relationship to levels of tissue plasminogen activator inhibitor antigen, plasminogen activator and their complexes.
Levin RI; Harpel PC; Harpel JG; Recht PA
Blood; 1989 Oct; 74(5):1635-43. PubMed ID: 2529003
[TBL] [Abstract][Full Text] [Related]
19. Behaviour of tissue plasminogen activator, plasminogen activator inhibitor 1 and their complex in various disease states.
Niwano H; Takahashi H; Tatewaki W; Wada K; Seki Y; Shibata A
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):389-93. PubMed ID: 1420814
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors.
Nakashima A; Kobayashi T; Terao T
Gynecol Obstet Invest; 1996; 42(2):95-101. PubMed ID: 8878712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
